DUBLIN--(BUSINESS WIRE)--The "US Clinical Trial Data Management Service Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering. There are over 8000 clinical ...

BOSTON--(BUSINESS WIRE)--eClinical Solutions, a global provider of digital clinical software and services, today announced that the company will present at a variety of global industry conferences in ...

BERKELEY HEIGHTS, N.J., April 29, 2025 /PRNewswire/ -- Axtria Inc., an AI-first data analytics innovator transforming life sciences, today announced the launch of LUCCID, short for LLM-based ...

MILWAUKEE, WI, November 19, 2024 (EZ Newswire) -- As biopharmaceutical sponsors face increasing challenges in securing investigative sites for their clinical trials, the ability to reduce ...

Lakshmi Priya Darshini Pulavarthi is a skilled Clinical Data Management professional with over a decade of experience managing data from Phase I-III clinical trials. With a strong educational ...

Healthcare providers receive data from many disparate sources: hospitals, doctors’ offices, labs and lab machines, medical devices, pharmacies, and more. Investment in the correct infrastructure to ...

In life science research, data comes in many forms - structured clinical trial tables, semi-structured instrument outputs, ...

The shift to risk-based quality management (RBQM) in clinical trials offers market opportunities in proactive risk strategies, focusing on patient safety and data integrity. Emphasizing digital ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. With more than a third of hospitals experiencing negative operating margins, healthcare ...

Trial management has become one of the most decisive factors in determining whether diagnostic and medtech innovations make it to market successfully. For companies developing in vitro diagnostics and ...

Mergers and acquisitions (M&As) are highly prevalent in the healthcare industry—a trend that will likely continue into the foreseeable future. The first half of 2024 saw 31 announced hospital M&As, ...

The CEO highlighted results from the REMAIN-1 Midpoint Cohort, where "Revita-treated patients lost an additional 2.5% of total body weight, while patients in the sham group regained about 10%, a ...